immune

Mirimus lab scientists preparing to test COVID-19 samples from recovered patients on April 8, 2020 in Brooklyn, New York. Misha Friedman | Getty Images A type of T-cell responsible for …

The vaccine showed better reactogenicity and safety outcomes, and enhanced humoral and cell-mediated immune responses compared with the Phase-1 trial Covaxin, India’s indigenous COVID-19 vaccine, showed enhanced immune response as …

The researchers sequenced 750 genomes of the novel coronavirus from infected individuals and analysed the mutations Some mutations in the novel coronavirus may not only enable it to evade antibodies, …

While the mutation did not change virus replication, the scientists said it significantly diminished binding of a proportion of both clinical antibodies and serum samples. (Subscribe to Science For All, …

The researchers found that the patients’ memory B cells — specifically those that produce antibodies against the coronavirus — did not decline in number People who recover from COVID-19 are …

People who recover from COVID-19 are protected against the novel coronavirus for at least six months, and likely much longer, according to a study which says the immune system evolves …

Indian drugmaker Bharat Biotech’s coronavirus vaccine, which has been authorized for use in the country, proved safe and produced an immune response in a small group of adults aged 18 …

Oxford’s COVID-19 vaccine candidate has a better immune response when a two full-dose regime is used rather than a full-dose followed by a half-dose booster, the university said on Thursday. …

The companies plan a Phase 2b study expected to start in February. If the data is positive, a global Phase 3 study could start in the second quarter of next …